2007
DOI: 10.1590/s1516-93322007000200012
|View full text |Cite
|
Sign up to set email alerts
|

Development and in vitro evaluation of extended-release theophylline matrix capsules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 19 publications
1
3
0
Order By: Relevance
“…The first-order model kinetics is the best fit with the R2 of 0.9577. This result is consistent with the previous report (Pinheiro et al, 2007). This result differs from an earlier report using capsules containing gelatin nanoparticles of Cantigi extract.…”
Section: Capsule Dosage Forms Containing Microcapsules Of Cantigi Ext...supporting
confidence: 91%
“…The first-order model kinetics is the best fit with the R2 of 0.9577. This result is consistent with the previous report (Pinheiro et al, 2007). This result differs from an earlier report using capsules containing gelatin nanoparticles of Cantigi extract.…”
Section: Capsule Dosage Forms Containing Microcapsules Of Cantigi Ext...supporting
confidence: 91%
“…while the B5 curve in the same figure (i.e., TPP content in the precursor solution = 0.04% (w/v)) shows the slowest drug releasing rate, with 90% of initially loaded TH issued within 5 hours. For comparison's sake, the dissolution profiles of the commercial capsules with prolonged release of TH micro granules in the medium of pH 7.5 was reported to have a rapid releasing rate, with nearly 100% of the initially loaded TH released within one hour 33 .…”
Section: Effect Of Processing Parameters (Drying Temperature and Air mentioning
confidence: 99%
“…HPMC was efficient in controlling the release of theophylline from the matrix of the capsules prepared by compounding. However, extendedrelease capsules containing 100 mg of theophylline (pellets) available in the market did not show prolonged release when submitted to the same test conditions [38].…”
Section: Cellulose Ether Derivatives In Sustained/controlled Release mentioning
confidence: 95%
“…The use of sodium carboxymethylcellulose or hydroxypropyl methylcellulose have also been reported in extended or slow-release systems [34][35][36][37][38][39][40]. These systems are most commonly obtained by the simple mixing of the drug with an appropriate inert matrix [39].…”
Section: Cellulose Acetate Phthalate (Cap)mentioning
confidence: 99%